Pfizer to Reorganize Into 3 Business Segments

Pfizer (NYSE: PFE  ) plans to internally separate its commercial operations into three separate business segments, the company announced today. Two of those segments will include what the company calls innovative business lines, and a third will include its value lines.

One of the innovative segments will include products that cover several therapeutic areas, including inflammation and immunology, CV/metabolic, neuroscience and pain, rare diseases, and women's and men's health. Those products will have market exclusivity beyond 2015.

The other innovative segment will include vaccines, oncology, and consumer health care, with each of those areas operating as a separate global business.

The value business segment will include products that have lost market exclusivity, as well as products that are mature, patient-protected, and expected to lose exclusivity through 2015 in most major markets. Those products will be positioned to provide lower-cost treatments to patients.

The value business line will also include biosimilar products and those that come about from current and future collaborations, such as with Mylan in Japan, Teuto in Brazil, and Hisun in China.

The three segments will be operating in developed as well as developing markets. In countries that don't require consultation with employee organizations, such as unions, the changes will take place in January. In other countries, the changes will take place after the necessary consultation.


Read/Post Comments (0) | Recommend This Article (2)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2565445, ~/Articles/ArticleHandler.aspx, 9/21/2014 4:20:39 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement